TTS Pharma

About:

TTS Pharma is a UK-based biotechnology company developing technologies to support the pharmacogenetic stratification of patients.

Website: http://ttspharma.com

Top Investors: The North West Fund

Description:

TTS Pharma was formed in late 2012 to acquire Transdermal Technology & Systems (TTS) Limited as part of a strategic investment and corporate restructuring to prepare it for growth and to enable the group to undertake activities in both Europe and Asia. TTS Limited is a wholly owned subsidiary of TTS Pharma and undertakes its operating activities primarily in UK.

Total Funding Amount:

10.9M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Liverpool, Liverpool, United Kingdom

Founded Date:

2012-01-01

Founders:

Mark Tucker

Number of Employees:

1-10

Last Funding Date:

2019-05-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai